MCID: OBS001
MIFTS: 47

Obstructive Jaundice malady

Category: Gastrointestinal diseases

Aliases & Classifications for Obstructive Jaundice

About this section

Aliases & Descriptions for Obstructive Jaundice:

Name: Obstructive Jaundice 11 13
Jaundice, Obstructive 37 66
Obstructive Hyperbilirubinemia 11
Cholestatic Jaundice Syndrome 11
 
Obstructive Jaundice Nos 11
Jaundice Cholestatic 48
Jaundice Obstructive 48
Cholestatic Jaundice 11

Classifications:



External Ids:

Disease Ontology11 DOID:13603
MeSH37 D041781
NCIt43 C34742

Summaries for Obstructive Jaundice

About this section
MalaCards based summary: Obstructive Jaundice, also known as jaundice, obstructive, is related to adenocarcinoma and eosinophilic gastroenteritis, and has symptoms including jaundice (not of newborn), yellow complexion and hepatocellular jaundice. An important gene associated with Obstructive Jaundice is ALB (Albumin), and among its related pathways are Hematopoietic Stem Cell Differentiation Pathways and Lineage-specific Markers and Mesenchymal Stem Cell Differentiation Pathways and Lineage-specific Markers. Affiliated tissues include liver, pancreas and lung, and related mouse phenotype homeostasis/metabolism.

Related Diseases for Obstructive Jaundice

About this section

Diseases related to Obstructive Jaundice via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 436)
idRelated DiseaseScoreTop Affiliating Genes
1adenocarcinoma31.0ALB, CD79A, REN
2eosinophilic gastroenteritis30.3CXCL8, IL6, TNF
3biliary tract disease30.2CD79A, CXCL8, TNF
4lymphedema27.9ALB, EDN1, F2, HGF, IL6, REN
5lutz richner landolt syndrome11.4
6severe intellectual disability-epilepsy-anal anomalies-distal phalangeal hypoplasia10.8IL6, REN
7scrub typhus10.8ALB, TNF
8wernicke-korsakoff syndrome10.8ALB, REN
9armfield syndrome10.8ALB, TTR
10aortic arch interruption10.8IL6, TNF
11panophthalmitis10.8EDN1, REN
12dystonia 410.7ALB, TTR
13hereditary antithrombin deficiency type i10.7ALB, F2
14anuria10.7ALB, REN
15uterine inflammatory disease10.7EDN1, REN
16non-langerhans-cell histiocytosis10.7F2, TNF
17hemometra10.7IL6, TNF
18tricho odonto onycho dermal syndrome10.6IL6, TNF
19iga glomerulonephritis10.6EDN1, REN
20acute zonal occult outer retinopathy10.6F2, IL6
21metabolic syndrome x10.6GPT, TNF
22fraxf syndrome10.6ALPP, GPT
23hypothyroidism10.6IL6, TNF, TTR
24marek disease10.6ALB, F2
25scrotum paget's disease10.6IL6, TNF
26gastric ulcer10.6ALB, IL6, TNF
27perrault syndrome10.6ALB, REN, TNF
28saethre-chotzen syndrome10.6HGF, IL6
29hypervitaminosis d10.6CD79A, TTR
30paraneoplastic pemphigus10.6F2, GPT
31corneal deposit10.6CXCL8, IL6
32broad ligament malignant neoplasm10.6ALB, EDN1, REN
33tarsal tunnel syndrome10.6CXCL8, IL6
34basidiobolomycosis10.6CXCL8, TNF
35gastric dilatation10.6EDN1, IL6, TNF
36pancreatitis10.6
37larynx carcinoma in situ10.5ALB, EDN1, TNF
38mastocytosis cutaneous with short stature conductive hearing loss and microtia10.5GPT, IL6, TNF
39monoclonal paraproteinemia10.5CD79A, IL6
40boutonneuse fever10.5ALB, CD79A
41transvestism10.5EDN1, TNF, TTR
42aneurysm of sinus of valsalva10.5CRP, IL6
43hypertrichosis10.5ALB, IL6, TNF
44mirizzi syndrome10.5
45vesicoureteral reflux10.5ALB, CD79A
46sarcoidosis, early-onset10.5HGF, IL6
47angiomyolipoma10.5ALB, IL6, TNF
48pancreatic solid pseudopapillary carcinoma10.5ALB, F2, TNF
49lupus erythematosus10.5ALB, ALPP, GPT
50lymphocytic colitis10.5CD79A, IL6, TNF

Graphical network of the top 20 diseases related to Obstructive Jaundice:



Diseases related to obstructive jaundice

Symptoms for Obstructive Jaundice

About this section

UMLS symptoms related to Obstructive Jaundice:


jaundice (not of newborn), yellow complexion, hepatocellular jaundice

Drugs & Therapeutics for Obstructive Jaundice

About this section

Drugs for Obstructive Jaundice (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 12)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
LactulosePhase 4924618-18-211333
Synonyms:
(2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5R)-4,5-dihydroxy-2,5-bis(hydroxymethyl)oxolan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
4-O-b-D-Galactopyranosyl-D-Fructofuranose
4-O-b-D-Galactopyranosyl-D-fructose
4-O-beta-D-Galactopyranosyl-D-Fructofuranose
4-O-beta-D-Galactopyranosyl-D-fructofuranose
4-O-beta-D-Galactopyranosyl-D-fructose
4-O-beta-delta-Galactopyranosyl-delta-Fructofuranose
4-O-beta-delta-Galactopyranosyl-delta-fructose
 
Bifiteral
Cephulac
D-Lactulose
Lactulosa
Lactulose
Lactulosum
delta-Lactulose
lactulosa
lactulosum
2
TrioxsalenPhase 2, Phase 3403902-71-45585
Synonyms:
2',4,8-Trimethylpsoralen
4,5',8-Trimethylpsoralen
4,8,5'-Trimethylpsoralen
6-Hydroxy-beta,2,7-trimethyl-5-benzofuranacrylic acid, delta-lactone
Trimethylpsoralen
Trioxisaleno
 
Trioxsalen
Trioxysalen
Trioxysalene
Trioxysalenum
Trisoralen
trimethylpsoralen
trioxysalen
trisoralen
3
bilirubinPhase 1, Phase 2107635-65-45280352
Synonyms:
(4Z,15Z)-Bilirubin IXa
(Z,Z)-Bilirubin IXa
1,10,19,22,23,24-Hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-Biline-8,12-dipropionate
1,10,19,22,23,24-Hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-Biline-8,12-dipropionic acid
2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-Biline-8,12-dipropanoate
2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-Biline-8,12-dipropanoic acid
3-(2-((3-(2-Carboxyethyl)-4-methyl-5-((3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-2-yl)methyl)-4-methyl-5-((4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-3-yl)propanoate
3-(2-((3-(2-Carboxyethyl)-4-methyl-5-((3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-2-yl)methyl)-4-methyl-5-((4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid
 
3-(2-((3-(2-Carboxyethyl)-4-methyl-5-[(Z)-(3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-1H-pyrrol-2-yl)methyl)-4-methyl-5-[(Z)-(4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene
3-[2-[[3-(2-Carboxyethyl)-5-[(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoate
3-[2-[[3-(2-Carboxyethyl)-5-[(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid
3-[2-[[3-(2-Carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoate
3-[2-[[3-(2-Carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid
Bilirubin
Bilirubin IX-alpha
Cholerythrin
Hematoidin
4
NeostigminePhase 1, Phase 29459-99-44456
Synonyms:
(m-Hydroxyphenyl)trimethylammonium dimethylcarbamate
(m-Hydroxyphenyl)trimethylammonium dimethylcarbamate (ester)
114-80-7 (bromide)
3-Trimethylammoniumphenyl N,N-dimethylcarbamate
3-[(dimethylcarbamoyl)oxy]-N,N,N-trimethylanilinium
3-{[(dimethylamino)carbonyl]oxy}-N,N,N-trimethylanilinium
51-60-5 (methyl sulfate)
59-99-4
AB00053807
AC1L1I7G
Ammonium, (m-hydroxyphenyl)trimethyl-, dimethylcarbamate (ester)
BPBio1_000634
BRD-K18922609-004-04-1
BRN 3615946
BSPBio_000576
Benzenaminium, 3-(((dimethylamino)carbonyl)oxy)-N,N,N-trimethyl- (9CI)
C07258
CAS-114-80-7
CCRIS 3079
CHEBI:7514
CID4456
D08261
DB01400
DivK1c_000165
DivK1c_000198
Eustigmin
Eustigmine
HMS2089A22
HSDB 3921
IDI1_000165
IDI1_000198
InChI=1/C12H19N2O2/c1-13(2)12(15)16-11-8-6-7-10(9-11)14(3,4)5/h6-9H,1-5H3/q+1
Intrastigmina
Juvastigmin
KBio1_000165
KBio1_000198
KBio2_001541
KBio2_004109
KBio2_006677
KBioGR_000623
KBioSS_001541
LS-18452
Lopac-N-2001
 
Lopac0_000816
NCGC00015730-01
NCGC00015730-02
NCGC00015730-03
NCGC00015730-04
NCGC00015730-08
NCGC00021658-03
NCGC00163240-01
NEOSTIGMINE
NINDS_000165
NINDS_000198
Neostigmin
Neostigmine (BAN)
Neostigmine [BAN]
Neostigmine omega
Neostigminum
Prestwick0_000468
Prestwick1_000468
Prestwick2_000468
Prestwick3_000468
Prostigmin
Prostigmin (TN)
Prostigmine
Prozerin
SPBio_001276
SPBio_002515
STL058953
Spectrum2_001278
Spectrum4_000072
Spectrum5_001234
Spectrum_001061
Synstigmin
Syntostigmine
UNII-3982TWQ96G
Vagostigmin
Vagostigmine
ZINC00001792
[3-(dimethylcarbamoyloxy)phenyl]-trimethyl-azanium
[3-(dimethylcarbamoyloxy)phenyl]-trimethyl-azanium bromide
[3-(dimethylcarbamoyloxy)phenyl]-trimethylazanium
bmse000762
m-Trimethylammoniumphenyldimethylcarbamate
nchembio.188-comp33
sulfonatooxymethane
5pancreatinPhase 2917
6
PancrelipasePhase 291753608-75-6
Synonyms:
1,4-alpha-D- glucan glucanohydrolase
PA
 
Pancreatic alpha-amylase precursor
Pancrelipase (amylase
lipase
protease)
7
MentholPhase 221842216-51-516666
Synonyms:
(−
()-Menthol
(+)-Neo-menthol
(+)-p-Menthan-3-ol
(+-)-(1R*,3R*,4S*)-Menthol
(+-)-Menthol
(+/-)-Menthol
(+/-)-p-Menthan-3-ol
(-)-(1R,3R,4S)-Menthol
(-)-Menthyl alcohol
(-)-menthol
(-)-p-Menthan-3-ol
(-)-trans-p-Menthan-cis-ol
(1R)-(-)-Menthol
(1R,2S,5R)-(-)-menthol
(1R,2S,5R)-Menthol
(1R,3R,4S)-(-)-MENTHOL
(1R,3R,4S)-(-)-Menthol
(1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol
(1S, 2S, 5R)-(+)-Neomenthol
(1S,2R,5R)-(+)-Isomenthol
(1S,2R,5S)-(+)-Menthol
(1S,2R,5S)-Menthol
(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol
(1r,2s,5r)-(-)-menthol
(L)-MENTHOL
(R)-(-)-Menthol
(r)-(-)-menthol
)-Menthol
--MENTHOL
1-Menthol
1490-04-6
15356-60-2
15356-70-4
15785_RIEDEL
15785_SIAL
19863P
2-Isopropyl-5-methylcyclohexanol
20747-49-3
2216-51-5
3-p-Menthol
4-Isopropyl-1-methylcyclohexan-3-ol
491-02-1
5-Methyl-2-(1-methylethyl)-cyclohexanol
5-Methyl-2-(1-methylethyl)cyclohexanol
5-methyl-2-(propan-2-yl)cyclohexanol
5-methyl-2-propan-2-ylcyclohexan-1-ol
551376_ALDRICH
551376_FLUKA
588733_ALDRICH
613290_ALDRICH
613290_FLUKA
63660_FLUKA
63670_ALDRICH
63670_FLUKA
63975-60-0
6C6A4A8C-A054-468C-A1F0-F29E39838CF2
89-78-1
98167-53-4
AC1L1B2E
AC1L28FR
AC1Q1NQ2
AC1Q2QQM
AI3-08161
AI3-52408
AKOS000119740
AR-1J3337
BB_NC-0057
BRN 1902288
BRN 3194263
BSPBio_003062
C00400
C10H20O
CCRIS 3728
CCRIS 375
CCRIS 4666
CCRIS 9231
CHEBI:15409
CHEBI:545611
CHEMBL256087
CHEMBL470670
CID1254
CID16666
Caswell No. 540
D-(-)-Menthol
D-p-Menthan-3-ol
D00064
D008610
D04849
D04918
DB00825
DivK1c_000820
EINECS 201-939-0
EINECS 207-724-8
EINECS 216-074-4
EINECS 218-690-9
EINECS 239-387-8
EINECS 239-388-3
EPA Pesticide Chemical Code 051601
FEMA No. 2665
Fisherman's friend lozenges
Fisherman's friend lozenges (TN)
HMS1922G13
HMS2092L14
HMS502I22
 
HSDB 5662
HSDB 593
Headache crystals
Hexahydrothymol
I06-1216
I14-7371
IDI1_000820
KBio1_000820
KBio2_000785
KBio2_003353
KBio2_005921
KBio3_002562
KBioSS_000785
L-(-)-Menthol
L-(-)-menthol
L-Menthol
L-menthol
LMPR0102090001
LS-2353
LS-57201
LS-886
LS-89531
LS-89533
Levomenthol
Levomenthol [INN:BAN]
Levomentholum
Levomentholum [INN-Latin]
Levomentol
M0321
M0545
M2772_SIAL
MENTHOL
MLS002207256
Menthacamphor
Menthol
Menthol (USP)
Menthol (VAN)
Menthol natural
Menthol natural, brazilian
Menthol racemic
Menthol racemique
Menthol racemique [French]
Menthol solution
Menthol, (1alpha,2beta,5alpha)-Isomer
Menthomenthol
Menthyl alcohol
MolPort-000-849-729
MolPort-001-793-392
NCGC00159382-02
NCGC00159382-03
NCGC00164247-01
NCGC00164247-02
NCI-C50000
NINDS_000820
NOOLISFMXDJSKH-KXUCPTDWBX
NSC 2603
NSC 62788
NSC2603
NSC62788
Neoisomenthol
Peppermint camphor
RACEMIC MENTHOL U.S.P.
Racementhol
Racementhol [INN:BAN]
Racementholum
Racementholum [INN-Latin]
Racementol
Racementol [INN-Spanish]
Racemic menthol
Robitussin Cough Drops
SDCCGMLS-0066659.P001
SMR001306785
SPBio_000869
SPECTRUM1503134
STK802468
Spectrum2_000855
Spectrum3_001561
Spectrum5_001060
Spectrum_000305
Tra-kill tracheal mite killer
U.S.P. Menthol
U.S.p. Menthol
UNII-BZ1R15MTK7
UNII-L7T10EIP3A
UNII-YS08XHA860
W266507_ALDRICH
W266523_ALDRICH
W266590_ALDRICH
WLN: L6TJ AY1&1 BQ D1
WLN: L6TJ AY1&1 DQ D1 -L
ZINC01482164
cis-1 ,3-trans-1,4-(+-)-menthol
cis-1,3-trans-1,4-(+-)-menthol
d,l-Menthol
d-Menthol
d-Neomenthol
dl-3-p-Menthanol
dl-Menthol
dl-Menthol (JP15)
l-(-)-Menthol
l-Menthol
l-Menthol (JP15)
l-Menthol (TN)
l-Menthol (natural)
nchembio862-comp1
p-Menthan-3-ol
rac-Menthol
8
Ursodeoxycholic acidPhase 283128-13-231401
Synonyms:
(3a,5b,7b)-3,7-dihydroxy-cholan-24-oate
(3a,5b,7b)-3,7-dihydroxy-cholan-24-oic acid
(3a,5b,7b)-3,7-dihydroxycholan-24-oic acid
(3alpha,5beta,7beta)-3,7-dihydroxycholan-24-oic acid
(3alpha,5beta,7beta,8xi)-3,7-dihydroxycholan-24-oic acid
(3α,5β,7β)-3,7-dihydroxycholan-24-oic acid
(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
128-13-2
17-beta-(1-Methyl-3-carboxypropyl)etiocholane-3-alpha,7-beta-diol
3 alpha,7 beta-Dihydroxy-5 beta-cholan-24-oic Acid
3,7-Dihydroxycholan-24-oic acid
3-alpha,7-beta-Dihydroxy-5-beta-cholanoic acid
3-alpha,7-beta-Dihydroxycholanic acid
3-alpha,7-beta-Dioxycholanic acid
3a,7b-Dihydroxy-5b-cholan-24-oate
3a,7b-Dihydroxy-5b-cholan-24-oic acid
3alpha,7beta-Dihydroxy-5beta-cholan-24-oic acid
3alpha,7beta-Dihydroxy-5beta-cholanic acid
4-10-00-01604 (Beilstein Handbook Reference)
50809-41-1
5beta-Cholan-24-oic acid-3alpha,7beta-diol
5beta-Cholanic Acid-3alpha,7beta-diol
7-beta-Hydroxylithocholic acid
7beta-Hydroxylithocholic acid
80225-86-1
AB00513977
AC-18919
AC-2081
AC1L1LJH
Acide ursodesoxycholique
Acide ursodesoxycholique [INN-French]
Acido ursodeossicolico
Acido ursodeossicolico [Italian]
Acido ursodeoxicolico
Acido ursodeoxicolico [INN-Spanish]
Acidum ursodeoxycholicum
Acidum ursodeoxycholicum [INN-Latin]
Actigall
Actigall (TN)
Antigall
Arsacol
BB_NC-2372
BPBio1_001052
BRN 3219888
BSPBio_000956
C07880
C24H40O4
CCRIS 5502
CHEBI:9907
CHEMBL1551
CHEMBL73390
CID11516715
CID31401
CPD-10534
CPD000058403
Cholan-24-oic acid, 3,7-dihydroxy-, (3-alpha,5-beta,7-beta)- (9CI)
Cholit-ursan
D00734
DB01586
Delursan
Deoxyursocholic Acid
Destolit
Deursil
Dom-ursodiol c
EINECS 204-879-3
HMS1570P18
 
ISO-URSODEOXYCHOLIC ACID
IU5
LMST04010033
LS-53033
Litursol
Lyeton
MLS000028461
MLS001066373
MolPort-001-794-630
MolPort-005-932-884
NCGC00179363-01
NCI60_028904
NSC 657950
NSC 683769
PHL-ursodiol c
PMS-ursodiol c
Peptarom
Prestwick0_000958
Prestwick1_000958
Prestwick2_000958
Prestwick3_000958
S1643_Selleck
SAM002264653
SMP2_000012
SMR000058403
SPBio_003105
Sodium Ursodeoxycholate
Solutrat
U-9000
U0030
U5127_SIGMA
UDCA
UDCS
UNII-724L30Y2QR
URSODEOXYCHOLIC ACID
UrSO
Urosdesoxycholate
Urosdesoxycholic acid
Urosiol
Ursacholic Acid
Ursacol
Urso
Urso (TN)
Urso 250
Urso DS
Urso Forte
Ursobilin
Ursochol
Ursodamor
Ursodeoxy cholic acid
Ursodeoxycholate
Ursodeoxycholic acid
Ursodeoxycholic acid (JP15/INN)
Ursodeoxycholic acid, UDCA, Ursosan, Ursofalk, Urso Forte, Udiliv, Ursodiol
Ursodeoxycholicacid
Ursodesoxycholic acid
Ursodexycholate
Ursodexycholic Acid
Ursodexycholic acid
Ursodiol
Ursodiol (USP)
Ursodiol [USAN]
Ursofalk
Ursolvan
Ursosan
chenodeoxycholic acid
ursodeoxycholate
ursodiol
9
PhenobarbitalPhase 15450-06-64763
Synonyms:
11097-06-6
46755-67-3
5-Ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione
5-Ethyl-5-phenyl-2,4,6-(1H,3H,5H)pyrimidinetrione
5-Ethyl-5-phenyl-2,4,6-pyrimidinetrione
5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione
5-Ethyl-5-phenylbarbituric acid
5-Phenyl-5-ethylbarbituric acid
5-ethyl-5-phenyl-1,3-diazinane-2,4,6-trione
5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione
5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione
50-06-6
57-30-7 (mono-hydrochloride salt)
AC1L1IWE
AI3-02726
AKOS000605404
Acido 5-fenil-5-etilbarbiturico
Acido 5-fenil-5-etilbarbiturico [Italian]
Adonal
Aephenal
Agrypnal
Amylofene
Antrocol
Aphenylbarbit
Aphenyletten
Arco-Lase Plus
Austrominal
BAS 00226811
BIDD:PXR0061
Barbenyl
Barbilehae (barbilettae)
Barbinal
Barbipenyl
Barbiphen
Barbiphenyl
Barbipil
Barbita
Barbivis
Barbonal
Barbophen
Bardorm
Bartol
Bialminal
Blu-Phen
Blu-phen
C07434
CCRIS 502
CHEBI:8069
CHEMBL40
CID4763
Cabronal
Calmetten
Calminal
Cardenal
Chardonna-2
Chinoin
Codibarbita
Coronaletta
Cratecil
D00506
DB01174
DEA No. 2285
Damoral
Dezibarbitur
DivK1c_000987
Donphen
Dormina
Dormiral
Dormital
Doscalun
Duneryl
EINECS 200-007-0
Elixir of phenobarbital
Ensobarb
Ensodorm
Epanal
Epidorm
Epilol
Episedal
Epsylone
Eskabarb
Etilfen
Euneryl
Fenbital
Fenemal
Fenobarbital
Fenobarbital [INN-Spanish]
Fenobarbitale
Fenobarbitale [DCIT]
Fenosed
Fenylettae
Gardenal
Gardepanyl
Glysoletten
Gustase-Plus
HMS503E15
HSDB 3157
Haplopan
Haplos
Helional
Hennoletten
Henotal
Hypnaletten
Hypnette
Hypno-Tablinetten
Hypnogen
Hypnolone
Hypnoltol
Hysteps
I06-0652
IDI1_000987
InChI=1/C12H12N2O3/c1-2-12(8-6-4-3-5-7-8)9(15)13-11(17)14-10(12)16/h3-7H,2H2,1H3,(H2,13,14,15,16,17
KBio1_000987
LS-135
Lefebar
Leonal
Lephebar
Lepinal
Lepinaletten
Levsin PB Drops and Tablets
Linasen
Liquital
Lixophen
Lubergal
Lubrokal
Lumen
Lumesettes
Lumesyn
 
Luminal
Luminal (TN)
Lumofridetten
Luphenil
Luramin
MLS001240232
MolPort-001-783-066
MolPort-003-959-166
Molinal
NCGC00159493-02
NCGC00159493-03
NINDS_000987
NSC 128143
NSC128143
NSC9848
Neurobarb
Nirvonal
Noptil
Nova-Pheno
Nunol
Oprea1_384816
P1636_SIGMA
PHENYLETHYLMALONYLUREA
PHOB
PUBERTAL PHENOBARBITAL STUDY
Pamine PB
Parkotal
Pharmetten
Phazyme-PB
Phen-Bar
Phenaemal
Phenemal
Phenemalum
Phenobal
Phenobarb
Phenobarbital
Phenobarbital (JP15/USP/INN)
Phenobarbital [USAN:INN:JAN]
Phenobarbital, Monosodium Salt
Phenobarbitalum
Phenobarbitalum [INN-Latin]
Phenobarbitalum [INN]
Phenobarbitol
Phenobarbitone
Phenobarbitonum
Phenobarbituric Acid
Phenobarbituric acid
Phenobarbyl
Phenoluric
Phenolurio
Phenomet
Phenonyl
Phenoturic
Phenyl-ethyl-barbituric acid
Phenylaethylbarbitursaeure
Phenylethyl barbituric acid
Phenylethylbarbiturate
Phenylethylbarbituric Acid
Phenylethylbarbituric acid
Phenylethylbarbitursaeure
Phenylethylmalonylurea
Phenyletten
Phenyral
Phob
Polcominal
Promptonal
SK-Phenobarbital
SMR000058986
Seda-Tablinen
Sedabar
Sedicat
Sedizorin
Sedlyn
Sedofen
Sedonal
Sedonal (sedative)
Sedonettes
Sedophen
Sevenal
Sinoratox
Solfoton
Solfoton Talpheno
Solfoton talpheno
Solu-Barb
Sombutol
Somnolens
Somnoletten
Somnosan
Somonal
Spasepilin
Starifen
Starilettae
Stental
Stental Extentabs
Talpheno
Teolaxin
Teoloxin
Thenobarbital
Theoloxin
Triabarb
Tridezibarbitur
Triphenatol
UNII-YQE403BP4D
Valprin 50-PB
Versomnal
WLN: T6VMVMV FHJ F2 FR
Zadoletten
Zadonal
aephe nal
barbapil
barbellen
barbellon
barbilehae
component of Antrocol
component of Bronkotabs
component of Hecadrol
component of Primatene P
component of Slowten
component of Tedral
component of Valpin 50-PB
d ezibarbitur
fen osed
le phebar
phenobarbital
phenobarbital (PB)
phenobarbitone
phenylral
seda-tabl inen
stental exte ntabs
theominal
10
Sevoflurane45328523-86-65206
Synonyms:
1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane
28523-86-6
AC-15484
AC1L1JU0
BRN 2041023
Bax 3084
C009250
C07520
C4H3F7O
CHEBI:9130
CHEMBL1200694
CID5206
D00547
DB01236
F0691
Fluoromethyl 1,1,1,3,3,3-Hexafluoroisopropyl Ether
Fluoromethyl 2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether
I14-13357
LS-67851
MR6S4
 
MR_6S4
MolPort-001-775-746
NCGC00167421-01
PC4681
Sevofluran
Sevoflurane
Sevoflurane (JAN/USAN/INN)
Sevoflurane [USAN:INN:BAN:JAN]
Sevoflurano
Sevoflurano [INN-Spanish]
Sevofluranum
Sevofluranum [INN-Latin]
Sevofrane
Sevorane
Sojourn
UNII-38LVP0K73A
Ultane
Ultane (TN)
ZINC01530810
fluoromethyl hexafluoroisopropyl ether
fluoromethyl-2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether
sevoflurane
11Ether55
12
Prednisone131853-03-25865
Synonyms:
(1S,2R,10S,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-5,17-dione
(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione
(8xi,9xi,14xi)-17,21-dihydroxypregna-1,4-diene-3,11,20-trione
.delta. E
.delta.(sup1)-Cortisone
.delta.-Cortelan
.delta.-Cortisone
.delta.-Cortone
.delta.-E
.delta.1-Cortisone
.delta.1-Dehydrocortisone
.delta.sone
1,2-Dehydrocortisone
1,4-Pregnadiene-17-alpha,21-diol-3,11,20-trione
1,4-Pregnadiene-17.alpha.,21-diol-3,11,20-trione
1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione
1-Cortisone
1-Dehydrocortisone
17,21-Dihydroxypregna-1,4-diene-3,11,20-trione
17alpha,21-Dihydroxy-1,4-pregnadiene-3,11,20-trione
53-03-2
68-59-7
81552_FLUKA
AC-11112
AC1L1LB2
AC1Q29EZ
ACon0_000082
ACon1_000297
AI3-52939
Adasone
Ancortone
Apo-Prednisone
Apo-prednisone
BPBio1_000323
BRD-K85883481-001-04-2
BSPBio_000293
Betapar
Bicortone
Bio-0649
C07370
C21H26O5
CCRIS 2646
CHEBI:8382
CHEMBL635
CID5865
CPD001227202
Cartancyl
Colisone
Cortan
Cortancyl
Cortidelt
Cotone
DB00635
Dacorten
Dacortin
Decortancyl
Decortin
Decortisyl
Dehydrocortisone
Dekortin
Delcortin
Dellacort
Dellacort A
Delta Cortelan
Delta E
Delta E.
Delta-Cortelan
Delta-Dome
Delta-cortelan
Delta-cortisone
Delta-cortone
Delta-dome
Deltacortene
Deltacortisone
Deltacortone
Deltasone
Deltasone, Liquid Pred, Orasone, Adasone, Deltacortisone,Prednisone
Deltison
Deltisona
Deltisone
Deltra
Di-Adreson
Diadreson
EINECS 200-160-3
Econosone
Encorton
Encortone
Enkortolon
Enkorton
Fernisone
Fiasone
HMS1568O15
HMS2090J13
HSDB 3168
Hostacortin
In-Sone
Incocortyl
 
Juvason
Kortancyl
LMST02030180
LS-1325
Liquid Pred
Lisacort
Lodotra
MEGxm0_000443
MLS001061265
MLS001304073
MLS001335907
MLS001335908
MLS002154191
MLS002207083
Me-Korti
Metacortandracin
Meticorten
Meticorten (Veterinary)
Metrevet (Veterinary)
MolPort-001-740-041
NCGC00090766-01
NCGC00090766-02
NCGC00090766-03
NCI-C04897
NCI60_000008
NSC 10023
NSC10023
Nisona
Nizon
Novoprednisone
Nurison
Orasone
Origen Prednisone
P1276
P6254_SIGMA
PRD
Panafcort
Panasol
Paracort
Parmenison
Pehacort
Precort
Predeltin
Prednicen-M
Prednicorm
Prednicort
Prednicot
Prednidib
Prednilonga
Prednison
Prednisona
Prednisona [INN-Spanish]
Prednisone
Prednisone Intensol
Prednisone [INN:BAN]
Prednisonum
Prednisonum [INN-Latin]
Prednitone
Prednizon
Prednovister
Presone
Prestwick0_000077
Prestwick1_000077
Prestwick2_000077
Prestwick3_000077
Prestwick_405
Pronison
Pronisone
Rectodelt
Retrocortine
S1622_Selleck
SAM002264641
SK-Prednisone
SMR000718760
SMR001227202
SPBio_002214
Servisone
Sone
Sterapred
Supercortil
U 6020
UNII-VB0R961HZT
Ultracorten
Ultracortene
WLN: L E5 B666 CV OV AHTTT&J A1 E1 FV1Q FQ
Winpred
Wojtab
ZINC03875357
Zenadrid
Zenadrid (veterinary)
Zenadrid [veterinary]
delta cortelan
delta(sup 1)-Cortisone
delta(sup 1)-Dehydrocortisone
delta-1-Cortisone
delta-1-Dehydrocortisone
delta-Cortisone
delta-Cortone

Interventional clinical trials:

(show all 41)
idNameStatusNCT IDPhase
1Human Kidney Histopathology in Obstructive JaundiceCompletedNCT01090193Phase 4
2Covered vs. Uncovered SEMS for Occluded Biliary Metal StentsCompletedNCT01315522Phase 4
3Randomised Trial Comparing Metal and Plastic Biliary Stents Stents for Palliating Malignant JaundiceRecruitingNCT00731419Phase 4
4A Prospective, Randomized Study Evaluating the Effect of Biliary Stenting on EAU-FNA in Patients With Suspected Malignant Biliary ObstructionTerminatedNCT01514058Phase 4
5Palliative Biliary Stenting on the Quality of Life of Patients With Unresectable Carcinoma Gallbladder With Hiliar Block.CompletedNCT00391183Phase 2, Phase 3
6RFA RCT for Pancreatic or Bile Duct CancerRecruitingNCT02166190Phase 3
7Endoscopic Biliary Radiofrequency Ablation of Malignant Distal Common Bile Duct StricturesRecruitingNCT01721174Phase 2, Phase 3
8Photodynamic Therapy (PDT) for Palliation of CholangiocarcinomaRecruitingNCT01755013Phase 2, Phase 3
9WallFlex Biliary Fully Covered (FC) Benign Stricture StudyActive, not recruitingNCT01014390Phase 3
10Preoperative Biliary Drainage for the Lower Malignant Obstructive JaundiceEnrolling by invitationNCT01744938Phase 3
11Comparison Between Two Methods of Bilateral Stenting for Malignant Hilar ObstructionWithdrawnNCT01622803Phase 3
12Metal or Plastic Stents to Relieve Obstruction of Obstructive Jaundice Prior to Resection of Periampullary Tumors.CompletedNCT02166840Phase 2
13Radiofrequency Ablation for Biliopancreatic MalignancyCompletedNCT02468076Phase 2
14Cholinergic Anti-inflammatory Pathway in Prevention & Treatment of the SIRS in Patients With Jaundice After Operation.RecruitingNCT02279147Phase 1, Phase 2
15SMOFlipid to Lessen the Severity of Neonatal CholestasisRecruitingNCT02721277Phase 1, Phase 2
16Role of Endoscopic RFA in Prolonging the Patency of Metal Stents in Patients With Malignant Obstructive JaundiceActive, not recruitingNCT01275768Phase 1, Phase 2
17The Effect of Ursodeoxycholic Acid in Liver Functional Restoration of Patients With Obstructive JaundiceNot yet recruitingNCT01688375Phase 2
18Evaluation of Preoperative Biliary Drainage Before PancreatoduodenectomyNot yet recruitingNCT01941342Phase 2
19Intra-luminal Radiofrequency Ablation for Inoperable Malignant Biliary StenosisEnrolling by invitationNCT02841800Phase 1
20Malignant Obstruction ZILVER Against Routine Therapy (MOZART I)CompletedNCT00196105
21Comparison Between Internal and External Preoperative Biliary Drainage in Periampullary CancersCompletedNCT01134276
22Safety and Efficacy of Photodynamic Therapy for Bile Duct Invasion of Hepatocellular CarcinomaCompletedNCT01506115
23Endoscopic Versus Percutaneous Drainage For Hilar Block in Gall Bladder CancerCompletedNCT00409864
24Biliary Cannulation During Endoscopic Retrograde Cholangiopancreatography: Precut Versus Conventional CannulationCompletedNCT02477228
25Outcome of Carbon Dioxide Versus Air Insufflations During Endoscopic Retrograde Cholangiopancreatography (ERCP)CompletedNCT01321203
26Biliary Atresia, Hepatic Buffer Response and SevofluraneCompletedNCT02471209
27Early Versus Late Cholecystectomy After Clearance of Common Bile Duct StonesCompletedNCT02460315
28Endoscopic Retrograde Cholangiopancreatography (ERCP) Based Sampling of Indeterminate Bile Duct StricturesCompletedNCT01580709
29Expression of BCRP in Icteric PatientsCompletedNCT00295360
30Immune Function in Patients With Obstructive JaundiceRecruitingNCT01367821
31Treatment of Obstructive Jaundice in Autoimmune Pancreatitis and/or Immunoglobulin G4-related Sclerosing Cholangitis by CorticosteroidsRecruitingNCT02797665
32Comparison of Metal and Plastic Stents for Preoperative Biliary DecompressionRecruitingNCT01191814
33Trial Comparing Metal Versus Plastic Stents for Preoperative Biliary DecompressionRecruitingNCT01675908
34Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal DisordersRecruitingNCT01438385
35Evaluation of Immune Function in Biliary Atresia Children With Prolonged JaundiceRecruitingNCT00155194
36Percutaneous Transhepatic Cholangiography Versus Endoscopic Ultrasound Guided Biliary DrainageRecruitingNCT01686425
37The Necessity of Bile Cultures in Patients With Acute CholangitisRecruitingNCT02601417
38A Study for Efficacy of Side-by-side Compared to Stent-in-stent Technique in the Endoscopic Management of Malignant Hilar Biliary ObstructionRecruitingNCT02659852
39Efficacy and Safety of Endobiliary Radiofrequency Ablation by Using a Novel RF Catheter (ELRA®) on Maintaining the Patency of Endobiliary Metal Drainage in Patients With Malignant Biliary Strictures : A Double-arm Comparable StudyRecruitingNCT02646514
40Comparison of Biliary Stenting Alone vs. Stenting With Photodynamic Therapy (PDT) During ERCPWithdrawnNCT01439685
41Comparison Between Unilateral Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction to Use a LCD StentWithdrawnNCT01875549

Search NIH Clinical Center for Obstructive Jaundice


Cochrane evidence based reviews: jaundice, obstructive

Genetic Tests for Obstructive Jaundice

About this section

Anatomical Context for Obstructive Jaundice

About this section

MalaCards organs/tissues related to Obstructive Jaundice:

34
Liver, Pancreas, Lung, Kidney, Brain, Lymph node, Myeloid

Animal Models for Obstructive Jaundice or affiliated genes

About this section

MGI Mouse Phenotypes related to Obstructive Jaundice:

39
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053766.1ALB, CD79A, CRP, EDN1, F2, IL6

Publications for Obstructive Jaundice

About this section

Articles related to Obstructive Jaundice:

(show top 50)    (show all 687)
idTitleAuthorsYear
1
A presenting with obstructive jaundice in pulmonary adenocarcinoma: a case report. (26379992)
2015
2
Clinical Approach to Patients With Obstructive Jaundice. (26615159)
2015
3
Percutaneous transhepatic cholangiobiopsy to determine the pathological cause of anastomotic stenosis after cholangiojejunostomy for malignant obstructive jaundice. (24156795)
2014
4
Obstructive jaundice due to von Hippel-Lindau disease-associated pancreatic lesions: A case report. (24959293)
2014
5
Acute pancreatitis and obstructive jaundice as initial complaints of hepatocellular carcinoma: case report. (24422982)
2014
6
Acute obstructive jaundice: a possible clinical manifestation of IPMT. Case report and review of the literature. (25263694)
2014
7
Obstructive jaundice as recurrence of lung adenocarcinoma. (22956154)
2013
8
Superiority of ceftriaxon to cefazolin in a rat model of obstructive jaundice: an experimental study. (23273144)
2013
9
Effect of biliary drainage on inducible nitric oxide synthase, CD14 and TGR5 expression in obstructive jaundice rats. (23613625)
2013
10
The effect of ursodeoxycholic acid in liver functional restoration of patients with obstructive jaundice after endoscopic treatment: a prospective, randomized, and controlled study. (24053627)
2013
11
Effective palliation of obstructive jaundice due to colorectal cancer liver metastasis. (24168172)
2013
12
Effects of Kupffer cell blockade on the hepatic expression of metallothionein and heme oxygenase genes in endotoxemic rats with obstructive jaundice. (22100509)
2012
13
Obstructive jaundice due to ductus hepaticus communis cyst in patient with liver cirrhosis. (22156359)
2011
14
Neurofibroma of the common bile duct: a rare cause of obstructive jaundice. (21741514)
2011
15
Effects of percutaneous transhepatic biliary drainage on renal function in patients with obstructive jaundice. (20690079)
2011
16
Identification of obstructive jaundice-related microRNAs in mouse liver. (21410023)
2010
17
Relapse of IgA lambda multiple myeloma presenting as obstructive jaundice and abdominal pain. (19295251)
2009
18
Tubulovillous adenoma in the common bile duct causing obstructive jaundice. (20163042)
2009
19
Magnetic compression biliary-enteric anastomosis for palliation of obstructive jaundice: initial clinical results. (19393505)
2009
20
Education and imaging. Hepatobiliary and pancreatic: Large cavernous hemangioma with obstructive jaundice. (19646022)
2009
21
Obstructive jaundice in neonates. (20426278)
2009
22
Effect of obstructive jaundice on hemodynamics in the liver and its clinical significance. (19822492)
2009
23
Preoperative biliary drainage for obstructive jaundice. (18677779)
2008
24
Adenocarcinoma of the pancreas complicated by obstructive jaundice in pregnancy. (18850437)
2008
25
Stenting and interventional radiology for obstructive jaundice in patients with unresectable biliary tract carcinomas. (18274846)
2008
26
Effect of honey on bacterial translocation and intestinal morphology in obstructive jaundice. (18528939)
2008
27
Obstructive jaundice caused by bile duct involvement in intra-abdominal non-Hodgkin lymphoma: An unusual initial manifestation. (17439827)
2007
28
Amiodarone hepatotoxicity complicating obstructive jaundice due to ampullary cancer. (17690045)
2007
29
Duodenal MALT lymphoma presenting with obstructive jaundice: report of a case and review of the literature. (19065720)
2007
30
Eosinophilic pancreatitis presenting as a pancreatic mass with obstructive jaundice. (16500417)
2006
31
Obstructive jaundice due to hepatobiliary cystadenoma or cystadenocarcinoma. (17007033)
2006
32
One-step palliative treatment method for obstructive jaundice caused by unresectable malignancies by percutaneous transhepatic insertion of an expandable metallic stent. (16688837)
2006
33
Phenylalanine breath test as a method to evaluate hepatic dysfunction in obstructive jaundice. (16226276)
2006
34
Burkitt's lymphoma: an unusual cause of obstructive jaundice. (16234085)
2005
35
Extrahepatic portal venous obstruction and obstructive jaundice: approach to management. (15610447)
2005
36
Evaluation of functional liver reserve in patients with obstructive jaundice undergoing hepatectomy. (15816473)
2005
37
Bombesin and neurotensin reduce endotoxemia, intestinal oxidative stress, and apoptosis in experimental obstructive jaundice. (15622004)
2005
38
Obstructive jaundice secondary to bile duct involvement with Hodgkin's disease: a case report. (15821813)
2005
39
Obstructive jaundice in a child with pancreatic hemangioma. (16047179)
2005
40
Three cases of small hepatocellular carcinoma presenting as obstructive jaundice. (18333040)
2004
41
Endotoxin challenge causes a proinflammatory state in obstructive jaundice. (15204955)
2004
42
Predictive value of risk factors in patients with obstructive jaundice. (15587757)
2004
43
Castleman's disease causing obstructive jaundice. (12663253)
2003
44
The effect of recombinant growth hormone on intestinal anastomotic wound healing in rats with obstructive jaundice. (16378269)
2002
45
Obstructive jaundice and acute cholangitis due to papillary stenosis. (10333725)
1999
46
The role of oxygen free radicals in acute renal failure complicating obstructive jaundice: an experimental study. (9515237)
1998
47
Bone marrow involvement and obstructive jaundice in Farber lipogranulomatosis: clinical and autopsy report of a new case. (8892023)
1996
48
Obstructive jaundice associated with polycystic liver disease. (9184868)
1996
49
Effects of cimetidine on IL-2 and T suppressor cell function in rats with obstructive jaundice. (7966522)
1994
50
Hereditary lymphedema and obstructive jaundice. (5544157)
1971

Variations for Obstructive Jaundice

About this section

Expression for genes affiliated with Obstructive Jaundice

About this section
Search GEO for disease gene expression data for Obstructive Jaundice.

Pathways for genes affiliated with Obstructive Jaundice

About this section

Pathways related to Obstructive Jaundice according to GeneCards Suite gene sharing:

(show all 21)
idSuper pathwaysScoreTop Affiliating Genes
19.7CD79A, IL6, TNF
29.7ALPP, CD79A, IL6
39.6ALB, F2, TTR
49.6EDN1, IL6, TNF
59.6CXCL8, IL6, TNF
69.6CXCL8, IL6, TNF
79.6CXCL8, IL6, TNF
89.6CXCL8, IL6, TNF
99.6CXCL8, IL6, TNF
109.6CXCL8, IL6, TNF
119.3ALB, ALPP, HGF, IL6
129.2CXCL8, EDN1, IL6, TNF
139.1CXCL8, HGF, IL6, TNF
149.1CXCL8, HGF, IL6, TNF
159.0CXCL8, LBP, TNF
16
Show member pathways
9.0CXCL8, IL6, LBP
17
Show member pathways
9.0CXCL8, IL6, LBP
18
Show member pathways
8.9ALB, CRP, F2, IL6, TNF
198.9CRP, IL6, LBP
20
Show member pathways
8.7CXCL8, IL6, LBP, TNF
21
Show member pathways
8.7CXCL8, IL6, LBP, TNF

GO Terms for genes affiliated with Obstructive Jaundice

About this section

Cellular components related to Obstructive Jaundice according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1extracellular spaceGO:00056155.7ALB, CRP, CXCL8, EDN1, F2, GPT
2extracellular regionGO:00055765.3ALB, CRP, CXCL8, EDN1, F2, HGF

Biological processes related to Obstructive Jaundice according to GeneCards Suite gene sharing:

(show all 19)
idNameGO IDScoreTop Affiliating Genes
1epithelial cell proliferation involved in salivary gland morphogenesisGO:006066410.6IL6, TNF
2negative regulation of hormone secretionGO:004688810.5EDN1, IL6
3cellular response to hepatocyte growth factor stimulusGO:003572910.2HGF, IL6
4positive regulation of smooth muscle cell proliferationGO:004866110.1EDN1, IL6, TNF
5negative regulation of lipid storageGO:00108889.9CRP, IL6, TNF
6negative regulation of growth of symbiont in hostGO:00441309.9LBP, TNF
7cellular response to interleukin-1GO:00713479.8CXCL8, EDN1, IL6
8positive regulation of sequence-specific DNA binding transcription factor activityGO:00510919.8EDN1, IL6, TNF
9cellular response to tumor necrosis factorGO:00713569.8CXCL8, EDN1, IL6
10positive regulation of chemokine productionGO:00327229.8IL6, LBP, TNF
11response to organic substanceGO:00100339.7ALB, REN, TNF
12opsonizationGO:00082289.6CRP, LBP
13positive regulation of nitric oxide biosynthetic processGO:00454299.5EDN1, IL6, TNF
14positive regulation of interleukin-6 productionGO:00327559.3IL6, LBP, TNF
15cellular response to lipopolysaccharideGO:00712229.1CXCL8, IL6, LBP, TNF
16acute-phase responseGO:00069539.0CRP, F2, IL6, LBP
17defense response to Gram-positive bacteriumGO:00508308.6CRP, IL6, LBP, TNF
18liver developmentGO:00018898.6HGF, LBP, NTS
19response to lipopolysaccharideGO:00324968.4EDN1, IL6, LBP, REN

Molecular functions related to Obstructive Jaundice according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1receptor bindingGO:00051028.4EDN1, F2, IL6, LBP, REN

Sources for Obstructive Jaundice

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
25GTR
26HGMD
27HMDB
28ICD10
29ICD10 via Orphanet
30ICD9CM
31IUPHAR
32KEGG
35MedGen
37MeSH
38MESH via Orphanet
39MGI
42NCI
43NCIt
44NDF-RT
47NINDS
48Novoseek
50OMIM
51OMIM via Orphanet
55PubMed
56QIAGEN
61SNOMED-CT via Orphanet
65Tumor Gene Family of Databases
66UMLS
67UMLS via Orphanet